Quan Zhou Jiang
Investor Relations Kontakt bei Zhejiang Heze Pharmaceutical Technology Co., Ltd.
Profil
Quan Zhou Jiang is currently the Board Secretary at Zhejiang Heze Pharmaceutical Technology Co., Ltd.
He previously worked as the Chief Financial Officer, Secretary & Director at Wanbangde Pharmaceutical Holding Group Co., Ltd.
from 2017 to 2020.
Prior to that, he held the position of Board Secretary & Deputy General Manager at Zhejiang Runtu Co., Ltd.
Aktive Positionen von Quan Zhou Jiang
Unternehmen | Position | Beginn |
---|---|---|
Zhejiang Heze Pharmaceutical Technology Co., Ltd.
Zhejiang Heze Pharmaceutical Technology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Zhejiang Heze Pharmaceutical Technology Co., Ltd. engages in the research and development of medicine. It offers generic drug development, consistency evaluation of generic drugs, pharmaceutical research and innovative drug development, and clinical trial services. The company was founded on October 27, 2006 and is headquartered in Hangzhou, China. | Investor Relations Kontakt | 30.09.2020 |
Ehemalige bekannte Positionen von Quan Zhou Jiang
Unternehmen | Position | Ende |
---|---|---|
WANBANGDE PHARMACEUTICAL HOLDING GROUP CO., LTD. | Finanzdirektor/CFO | 09.03.2020 |
ZHEJIANG RUNTU CO., LTD. | Unternehmenssekretär | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ZHEJIANG RUNTU CO., LTD. | Process Industries |
WANBANGDE PHARMACEUTICAL HOLDING GROUP CO., LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
Zhejiang Heze Pharmaceutical Technology Co., Ltd.
Zhejiang Heze Pharmaceutical Technology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Zhejiang Heze Pharmaceutical Technology Co., Ltd. engages in the research and development of medicine. It offers generic drug development, consistency evaluation of generic drugs, pharmaceutical research and innovative drug development, and clinical trial services. The company was founded on October 27, 2006 and is headquartered in Hangzhou, China. | Commercial Services |